Gordon Guo

ORCID: 0000-0001-8821-1803
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MicroRNA in disease regulation
  • Prostate Cancer Diagnosis and Treatment
  • Circular RNAs in diseases
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Bladder and Urothelial Cancer Treatments
  • Cancer-related molecular mechanisms research
  • Urinary and Genital Oncology Studies
  • Ovarian cancer diagnosis and treatment
  • RNA Research and Splicing
  • Renal and related cancers
  • Glioma Diagnosis and Treatment
  • Management of metastatic bone disease
  • Advanced X-ray and CT Imaging
  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Extracellular vesicles in disease
  • Renal Diseases and Glomerulopathies
  • Endometrial and Cervical Cancer Treatments
  • MRI in cancer diagnosis
  • Epigenetics and DNA Methylation
  • Radiopharmaceutical Chemistry and Applications
  • Genetic and Kidney Cyst Diseases
  • Oral health in cancer treatment
  • Dysphagia Assessment and Management

Indiana University – Purdue University Indianapolis
2016-2022

University Hospitals Seidman Cancer Center
2021

Indiana University Health
2020

Indiana University School of Medicine
2016-2019

Indiana University
2018

University of Manitoba
2012-2016

CancerCare Manitoba
2016

University of Toronto
2004

Mount Sinai Hospital
2004

Lunenfeld-Tanenbaum Research Institute
2004

// Henan Zhao 1 , Xiaotang Yu Yanfang Ding Jinyao Guang Wang Xian Wu Jiyong Jiang 2 Chun Peng 3 Gordon Zhuo Guo 4 Shiying Cui Dalian Medical University, Dalian, China Obstetrics and Gynecology Hospital, Department of Biology, York Toronto, Canada Radiation Oncology, Indiana University School Medicine, Indianapolis, IN, USA Correspondence to: Cui, email: scui2003@dlmedu.edu.cn 2501532244@qq.com Guo, gguo1@IUhealth.org Keywords: ovarian cancer, cisplatin, chemoresisitance, miR-770-5p, ERCC2...

10.18632/oncotarget.10736 article EN Oncotarget 2016-07-20

The glomerular filtration barrier separates the blood from urinary space. Nephrin is a transmembrane protein that belongs to immunoglobulin superfamily and localized slit diaphragms are critical component of this barrier. Mutations in nephrin gene (NPHS1) lead congenital Finnish nephropathy, whereas alterations level expression have been identified wide range acquired diseases. A 186-bp fragment human NPHS1 promoter capable directing podocyte-specific beta-galactosidase transgene when placed...

10.1097/01.asn.0000143474.91362.c4 article EN Journal of the American Society of Nephrology 2004-10-23

One of the best prognostic predictors for patients with epithelial ovarian cancer is Federation Obstetrics and Gynecology (FIGO) stage at diagnosis. Advanced-stage serous carcinoma (OSC) generally have poor prognosis. The goal this study to develop validate a miRNA expression profile that can differentiate OSC early advanced stages its correlation prognosis OSC. To identify unique microRNA (miRNA) pattern associated progression stages, microarray was performed using Chinese tumor bank...

10.1007/s13277-013-0928-3 article EN Tumor Biology 2013-07-08

Improved insight into the molecular and genetic profile of different types epithelial ovarian cancer (EOC) is required for understanding carcinogenesis EOC may potentially be exploited by future targeted therapies. The aim present study was to identify a unique microRNA (miRNA) patterns key miRNAs, which assist in predicting progression prognosis high‑grade serous carcinoma (HGSC) clear cell (CCC). To miRNA associated with HGSC CCC, microarray performed using Chinese tumor bank specimens...

10.3892/mmr.2015.4485 article EN cc-by-nc-nd Molecular Medicine Reports 2015-10-26
Coming Soon ...